Table 6.

Lessons learnt for the assessment of medical device software for sustained adoption of future digital health interventions.

eHealth strategy	Lessons learnt
Telehealth	Digital health tools that engage consumers for lifestyle, wellness, and health-related purposes, which typically do not require regulatory oversight, do not ensure value generation.
Integrated care	Evidence-based MDSWa that allow all stakeholders in the care continuum to collaborate and to access, share, aggregate, and visualize meaningful data daily, are expected to contribute the most to health care efficiency generation.
Digital therapeutics	Digital therapeutics that win public reimbursement must have solid proof of their efficacy/effectiveness. A market strategy or a MDSW regulation that helps build that proof is therefore essential. Real usage data for digital therapeutics and associated evaluations should determine national health coverage.

^aMDSW: medical device software.